Gastric Disease Clinical Trial
Official title:
Feasibility and Safety of PillBot™ - Remotely Controlled Capsule Endoscopy: A Feasibility Study
The PillBot System is an endoscopic capsule imaging system intended for visualization of the stomach. In contrast to currently used passive capsule endoscopy systems, and FDA cleared active magnetic system, the PillBot System uses active, motorized propulsion technology to facilitate the navigation and positioning of the capsule within the stomach anatomy for imaging of the gastric mucosa by an operator
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02105506 -
Safety and Feasibility of TachoSil®: Application on Esophageal Anastomoses
|
N/A | |
Completed |
NCT03198871 -
IV Acetaminophen for Post-Operative Pain Management in Enhanced Recovery After Surgery (ERAS) Population
|
Phase 4 | |
Not yet recruiting |
NCT03092414 -
Linked Color Imaging Based CMV Diagnosis for Gastric Mucosal Lesions
|
N/A | |
Completed |
NCT03776916 -
Application of Simethicone in Esophagogastroscopy
|
N/A | |
Not yet recruiting |
NCT06273319 -
The Effect of Oxygen Application With Double Nasal Cannula on Respiratory Complications
|
N/A | |
Not yet recruiting |
NCT02994472 -
Gastric Emptying: in Vivo Studies in Healthy Volunteers
|
N/A | |
Recruiting |
NCT03267355 -
Indications and Outcomes of Endoscopic Ultrasound in Tanta
|
N/A | |
Completed |
NCT01322737 -
Feasibility Trial to Evaluate the Ability of the SuMO Tissue Access and Resection System
|
N/A | |
Completed |
NCT04111393 -
Transoral Removal of Specimen During Laparoscopic Gastric Resection
|
||
Recruiting |
NCT05249933 -
Pronase Granules in Gastric Cleaning
|
Phase 2/Phase 3 | |
Completed |
NCT04479423 -
The Usage of Soda-Water in Gastric Preparation for Magnetically Controlled Capsule Endoscopy
|
N/A | |
Completed |
NCT05392452 -
Fully Closed-Loop Insulin Delivery in Abdominal Surgery (CLAB)
|
N/A | |
Not yet recruiting |
NCT05801055 -
A Study to Evaluate Endoscopic Visibility of Stomach After a Combination Drink of N-acetylcysteine and Simethicone
|
Phase 3 |